发明名称 Novel diuretics
摘要 An advantageous diuretic action by excretion of water, sodium and chloride ions, with reduced excretion of potassium ions, is effected by combined administration of a 19-oxygenated steroid compound of the pregnane series of the formula <IMAGE> (I) wherein Ra represents a hydrogen atom, and Rb represents an alpha -oriented lower alkanoylthio group, or Ra and Rb together represent a carbon-carbon bond or an alpha - or beta -oriented methylene radical, R represents a free hydroxymethyl group or a hydroxymethyl group etherified by a lower alkyl or esterified by a lower alkanoyl; or represents a carboxyl group or a lower alkoxycarbonyl group, and R2 represents a hydrogen atom or the acyl radical Ac of a carboxylic acid, as the aldosterone-antagonising component A on the one hand, and, on the other hand, of a conventional diuretic which is unspecific in respect of electrolyte excretion, e.g. a diuretically effective derivative of benzothiadiazine, benzenesulfonamide, phenoxyacetic acid, benzofuran-2-carboxylic acid or 2,3-dihydrobenzofuran-2-carboxylic acid, as component B. The two components A and B can be administered separately or together as an appropriate composition or pharmaceutical preparation.
申请公布号 US4261985(A) 申请公布日期 1981.04.14
申请号 US19790094266 申请日期 1979.11.14
申请人 CIBA-GEIGY CORPORATION 发明人 BIOLLAZ, MICHEL
分类号 A61K31/57;A61K31/63;A61K31/635;A61P5/38;(IPC1-7):A61K31/56 主分类号 A61K31/57
代理机构 代理人
主权项
地址